
Glimepiride (3mg) + Metformin (1000mg)
Active composition
+1 more active ingredient
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Jubiglim M3 Forte Tablet PR is a combination oral antidiabetic medication containing Glimepiride 3mg and Metformin 1000mg, designed for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, functions by stimulating pancreatic beta cells to increase insulin secretion, thereby improving glycemic control. Metformin, a biguanide, primarily reduces hepatic glucose production and enhances peripheral insulin sensitivity, contributing to better glucose uptake and utilization. The combination of these two agents provides complementary mechanisms of action, offering effective control of blood glucose levels in patients inadequately managed by diet and exercise alone. Jubiglim M3 Forte Tablet PR is indicated for adults with type 2 diabetes who require dual therapy to achieve target glycemic goals. It should be used as part of a comprehensive diabetes management plan including diet, exercise, and regular monitoring of blood glucose. Caution is advised in patients with renal impairment, hepatic dysfunction, or conditions predisposing to lactic acidosis. Common side effects may include hypoglycemia, gastrointestinal disturbances, and weight gain. Regular monitoring of blood glucose and periodic assessment of renal function are recommended during therapy to ensure safety and efficacy.
How to use Jubiglim M Tablet PR Use it as advised by your doctor or check the label for directions before use. Jubiglim M3 Forte Tablet PR is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Jubiglim M3 Forte Tablet PR.
High Risk
Jubiglim M3 Forte Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Jubiglim M3 Forte Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Jubiglim M3 Forte Tablet PR may be needed. Please consult your doctor. Jubiglim M3 Forte Tablet PR is generally started with a low dose in patients with mild to moderate liver disease, and its use is not recommended in patients with severe liver disease.
Regular Checkup
Jubiglim M3 Forte Tablet PR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Jubiglim M3 Forte Tablet PR should be used with caution in patients with kidney disease. Dose adjustment of Jubiglim M3 Forte Tablet PR may be needed. Please consult your doctor. Use of Jubiglim M3 Forte Tablet PR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function tests is advisable while you are taking this medicine.
Regular Checkup
0 reviews for Jubiglim M3 Forte Tablet PR

Glimepiride (3mg) + Metformin (1000mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Jubiglim M3 Forte Tablet PR is a combination oral antidiabetic medication containing Glimepiride 3mg and Metformin 1000mg, designed for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, functions by stimulating pancreatic beta cells to increase insulin secretion, thereby improving glycemic control. Metformin, a biguanide, primarily reduces hepatic glucose production and enhances peripheral insulin sensitivity, contributing to better glucose uptake and utilization. The combination of these two agents provides complementary mechanisms of action, offering effective control of blood glucose levels in patients inadequately managed by diet and exercise alone. Jubiglim M3 Forte Tablet PR is indicated for adults with type 2 diabetes who require dual therapy to achieve target glycemic goals. It should be used as part of a comprehensive diabetes management plan including diet, exercise, and regular monitoring of blood glucose. Caution is advised in patients with renal impairment, hepatic dysfunction, or conditions predisposing to lactic acidosis. Common side effects may include hypoglycemia, gastrointestinal disturbances, and weight gain. Regular monitoring of blood glucose and periodic assessment of renal function are recommended during therapy to ensure safety and efficacy.
How to use Jubiglim M Tablet PR Use it as advised by your doctor or check the label for directions before use. Jubiglim M3 Forte Tablet PR is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Jubiglim M3 Forte Tablet PR.
High Risk
Jubiglim M3 Forte Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Jubiglim M3 Forte Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Jubiglim M3 Forte Tablet PR may be needed. Please consult your doctor. Jubiglim M3 Forte Tablet PR is generally started with a low dose in patients with mild to moderate liver disease, and its use is not recommended in patients with severe liver disease.
Regular Checkup
Jubiglim M3 Forte Tablet PR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Jubiglim M3 Forte Tablet PR should be used with caution in patients with kidney disease. Dose adjustment of Jubiglim M3 Forte Tablet PR may be needed. Please consult your doctor. Use of Jubiglim M3 Forte Tablet PR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function tests is advisable while you are taking this medicine.
Regular Checkup
0 reviews for Jubiglim M3 Forte Tablet PR













